BIOREACTOR STUDIOS
Annual accounts 2025
micro format, filed on 02-06-2026, 59 days before the deadlineTurnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.
Turnover ≈ €550. Estimated: probably between €290 and €1,000.
Balance sheet
balance sheet total €39,051 on 31-12-2025Position in the sector
2.7%
Higher than 10% of 21,217 companies in 2025.
1.01
Higher than 18% of 20,581 companies in 2025.
-2.5%
Higher than 14% of 20,756 companies in 2025.
Net result: bottom quarter · Equity: bottom quarter · Balance sheet total: bottom quarter · Working capital: bottom quarter
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2025 |
|---|---|---|
| Balance sheet: assets | ||
20/58 |
39,051 | |
20 |
743 | |
29/58 |
38,308 | |
40/41 |
30,264 | |
40 |
500 | |
41 |
29,764 | |
54/58 |
8,044 | |
| Balance sheet: equity and liabilities | ||
10/49 |
39,051 | |
10/15 |
1,042 | |
10/11 |
2,000 | |
14 |
-958 | |
17/49 |
38,009 | |
42/48 |
38,009 | |
44 |
6,628 | |
440/4 |
6,628 | |
45 |
547 | |
450/3 |
547 | |
47/48 |
30,834 | |
| Income statement | ||
9900 |
100 | |
630 |
186 | |
640/8 |
787 | |
9901 |
-872 | |
75/76B |
6 | |
75 |
6 | |
65/66B |
73 | |
65 |
73 | |
9903 |
-939 | |
67/77 |
18 | |
9904 |
-958 | |
9905 |
-958 | |
| Appropriation of the result | ||
9906 |
-958 | |
| Document | ||
The notes to these accounts have 1 item. You find them in the accounts filed with the NBB.
Source: Annual accounts 2025 at the NBB, filed on 02-06-2026.
Filings
each dot is a set of accounts, on the day it reached the National Bank| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 31-12-2025 | micro format | 02-06-2026 | 2026-00137011 |
Subsidies and aid
Flemish government 2025, 1 entry, €85,000 awarded, €42,500 paid
Key figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2025 |
|---|---|---|
| -687 | ||
| -772 | ||
| 299 | ||
| 2.7% | ||
| 1.01 | ||
| 36.46 | ||
| -91.9% | ||
| -2.5% | ||
| -9.36 |
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Insights on BIOREACTOR STUDIOS
Debt's share of the balance-sheet total is 97.3%.